- Home
- SAIA vs BAX Comparison
SAIA vs BAX Comparison
Compare SAIA & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SAIA | BAX |
|---|---|---|
| Founded | 1924 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 10.0B |
| IPO Year | 2002 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SAIA | BAX |
|---|---|---|
| Price | $466.51 | $19.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 9 |
| Target Price | ★ $391.06 | $21.00 |
| AVG Volume (30 Days) | 308.0K | ★ 5.9M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.86 | N/A |
| Revenue | $3,234,286,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $7.29 | $1.96 |
| Revenue Next Year | $9.08 | $2.22 |
| P/E Ratio | $253.30 | ★ N/A |
| Revenue Growth | 0.79 | ★ 5.72 |
| 52 Week Low | $249.01 | $15.73 |
| 52 Week High | $485.00 | $32.04 |
Technical Indicators
Market Signals| Indicator | SAIA | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 53.78 | 59.93 |
| Support Level | $324.03 | $18.95 |
| Resistance Level | N/A | $19.90 |
| Average True Range (ATR) | 17.49 | 0.62 |
| MACD | -1.86 | 0.04 |
| Stochastic Oscillator | 47.44 | 76.60 |
Price Performance
Historical ComparisonAbout SAIA Saia Inc.
Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.